GLD vs PTGX
SPDR® Gold Shares (GLD) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
SPDR® Gold Shares (GLD) common stock listed on NYSE ARCA.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
GLD does not have a complete income-statement cache yet.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
GLD currently screens at market cap $0. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the GLD and PTGX stock pages for the full models.
Not investment advice.